Consumers Join Forces to Protest Against Antidepressant Paxil and Kickoff Boycot

[Guest guest]

SSRI-Research@

Sun, 18 Sep 2005 19:48:42 -0400

[sSRI-Research] Consumers Join Forces to Protest Against

Antidepressant Paxil and Kickoff Boycott of Drug Company GlaxoSmithKline

 

 

 

 

Consumers Join Forces to Protest Against Antidepressant Paxil

and Kickoff Boycott of Drug Company GlaxoSmithKline

 

News Released: August 27, 2005

 

http://www.prleap.com/pr/13734/

 

(PRLEAP.COM) CHATTANOOGA, TN, August 27th, 2005/PRLeap/ -

Consumer drug advocates from across the United States, Canada and

elsewhere are converging on drug giant GlaxoSmithKline's US corporate

headquarters located in Philadelphia, PA this September 26th through

28th in what could turn out to be a massive demonstration against the

company's top selling drug called Paxil. The event is called the

" Paxil Protest. "

 

" Paxil is a dangerous and defective drug. That is absolutely the

case, " said Rob Robinson, the event's organizer. " The swath of

devastation, misery and sometimes death which Paxil has unleashed the

world over is simply staggering. Yet GlaxoSmithKline has done

everything in its power to keep the sinister truth about Paxil from

going public. What's at stake for the company is a multibillion dollar

revenue stream that sales of Paxil have generated for almost ten years. "

 

" GlaxoSmithKline has claimed since 1992, " Robinson said, " that

Paxil is 'safe and effective' after it was approved by the Food and

Drug Administration - end of story. But it's the beginning of the

story which GSK conveniently forgets, or rather doesn't want the world

to know about, and that is the fact that Paxil's FDA approval was

based on the company's submission of fraudulent Phase III clinical

trials. As such, GSK's claim that Paxil is 'safe and effective' is

specious at best. "

 

" The truth is Paxil represents the greatest fraud ever

perpetuated within the pharmaceuticals industry, " Robinson said. " But

thanks to the unsparing efforts of attorneys representing Paxil

victims evidence of this fraud has been uncovered in GlaxoSmithKline's

confidential files. One trial and it all comes out. And that is going

to be one huge news story - on the order of Merck's Vioxx. "

 

A much anticipated Paxil trial set to take place May 2nd of this

year was delayed for at least another six months. Robinson says he is

not surprised: " GSK has spent hundreds of millions of dollars fighting

to keep the truth about Paxil from coming out, but at the end of day

I'm confident the company's efforts will fail. "

 

Approximately 5,000 U.S. citizens have filed suit against

GlaxoSmithKline asserting they became addicted to Paxil and then

suffered withdrawals when quitting the drug as a consequence of the

company failing to warn them of the drug's dangers. Several thousand

more persons have sued GlaxoSmithKline in the UK on the same basis.

" Paxil's reach extends into medicine cabinets the world over, and cuts

across all social classes, " Robinson said. " Paxil is an equal

opportunity destroyer. "

 

Some lawsuits filed against GlaxoSmithKline are on behalf of

patients who started Paxil - only to discover they could not stop

taking the drug, even with expert medical help. (One patient in

Britain was told by her doctors that 'heroin would have been easier to

wean [herself] off and recover from.')

 

" Paxil withdrawal symptoms can be so severe and protracted it

requires an almost superhuman strength to endure them, " Robinson said.

" Not surprisingly, some people cannot, and as a consequence commit

suicide. Others victims have resumed use of Paxil to escape withdrawal

symptoms, but will have to take the drug for the rest of their lives

whether they want to or not. In other words, they've become lifetime

Paxil addicts. "

 

Robinson stated that a review of the medical literature shows

that, on average, over one-third of people taking Paxil for any

extended period of time experience withdrawal symptoms, and of those,

21% experience severe withdrawal symptoms. In the clinical trials of

Paxil, a significant percentage of patients (up to 50% according to

some studies) experienced withdrawal.

 

" There is a huge disconnect between what GSK tells the public

about Paxil, and what the truth about Paxil is. That disconnect

extends to GlaxoSmithKline's labeling of the drug throughout the

world. GSK is a very big company with an even bigger problem of

telling the truth, " Robinson said.

 

In an October 19, 2000 deposition taken of Dr. David Wheadon,

Senior Vice President of Regulatory Affairs and Product Professional

Services for GlaxoSmithKline, Dr. Wheadon stated " there have been a

number of systematic studies in humans looking at the potential for

Paxil for abuse, tolerance and physical dependence. So actually, there

is data to date to negate the statement that it has not been

systematically studied, because, in fact, it has been. " However,

Paxil's June, 2005 drug labeling states " Paxil has not been

systematically studied in animals or humans for its potential for

abuse, tolerance or physical dependence. "

 

At the time of Dr. Wheadon's testimony Paxil's U.S. drug label

claimed: " Paxil is non-habit forming, may cause mild, usually

temporary, side effects in some individuals " and further that Paxil

" has been studied both in short-term and long-term use and is not

associated with dependence or addiction. " " Those claims are now known

to be utterly false, " said Robinson.

 

" No discerning member of the public, or the press, will believe

that Dr. Wheadon was simply mistaken or ill-informed at the time of

his year 2000 deposition, " Robinson said. He (Wheadon) knows as much

about Paxil as anybody at Glaxo; all one has to do is peruse his sworn

testimony to see that's clearly the case. " (Access Dr. Wheadon's

complete testimony at the Paxil Protest web site.)

 

Dr. Wheadon's association with Paxil spans two decades; he was

part of the original GSK team which presented Paxil's clinical trials

during the FDA's October 5th, 1992 hearing wherein the company first

sought - and later gained - the agency's approval for the drug.

 

A Paxil Protest web site, launched on August 8th, 2005, has

already received over a quarter of a million 'hits.' " The response

from the public has been one of exuberance. Which is hardly surprising

given the fact that this represents the first time in history a

multinational drug company has successfully been targeted using the

Internet as a public relations weapon, " Robinson said. " The Internet

is providing the public the matchless ability to organize and direct

participants 'on the ground' and to further respond in real time to a

highly fluid and dynamic public relations environment. It's almost

like having the equivalent of an AWACS radar plane circling over a

public relations battlefield. "

 

The Paxil Protest web site, well organized and easy to navigate,

lays out a compelling indictment not only of Paxil, but also of

GlaxoSmithKline. " Virtually all of what you'll see at the Paxil

Protest web site was assembled from news stories, medical journals,

depositions and the like. It was simply a matter of pulling all the

facts together into one big package for the public, " Robinson said. " I

challenge GlaxoSmithKline to dispute the accuracy and veracity of

anything published to the web site. "

 

The Paxil Protest web site also includes important information

for Paxil users who might wish to quit the drug. " What I did not want

to have happen is to have Paxil users come to the site, panic, and

then abruptly quit the drug. The consequences could be disastrous.

That's why an entire web page addresses the issue of how to get off

Paxil safely, or as safely as possible. "

 

" I am confident the public as well as the media will discover

information that is newsworthy and highly informative on virtually

every page of the Paxil Protest web site " Robinson said. " Plenty of

story angles to be had, " he added.

 

Robinson, a Paxil survivor himself, said it took several years

of intermittent but intensive research to assemble the information

presented at the Paxil Protest web site. " My goal was to make it as

easy as possible for the public to get to the truth about Paxil - the

sinister truth which GlaxosmithKline hides from the world. " He

describes the Paxil Protest web site as 'the definitive Paxil

Information Clearinghouse.'

 

As many as 1,000 or more protesters might attend the Paxil

Protest. " We simply have no way of forecasting how many people might

show up; after all, the call to action is going out the world over, "

Robinson said.

 

Victims and survivors of other SSRI drugs such as Prozac,

Effexor and Zoloft are also expected to attend in a show of community

support.

 

Contact:

 

Rob Robinson

Event Coordinator

The Paxil Protest

eventcoordinator

423-265-5604

http://www.paxilprotest.com

 

 

 

Contact Information

Rob Robinson

The Paxil Protest

Email The Paxil Protest

423-265-5604